Follow on Google News News By Tag Industry News Country(s) Industry News
Follow on Google News | inABLE® technology helps unlock the secrets of cyclic peptidesBy: Ingenza Ltd “Our aim is to develop a flexible, cost-effective technology platform for the production of drugs based on cyanobactin cyclic peptides. These peptides – which are native to many marine and freshwater species – show excellent promise against diseases such as drug resistant tumours, but their gene clusters are complex and difficult to manipulate. Ingenza’s inABLE technology allows us to shuffle genes very quickly, eliminating laborious, time-consuming manual processes and allowing the generation of large quantities of peptides.” “This technology has been the key to a successful ongoing collaboration between the University of Aberdeen, Ingenza and Professor Jim Naismith at the University of St Andrews, to produce novel cyclic peptides for therapeutic testing. The next step is to expand the number of organisms we are investigating and generate larger quantities of these cyclic peptides, enabling industrial partnerships to be formed to develop new therapeutics targeting specific disease areas.” End
Account Email Address Disclaimer Report Abuse
|
|